4 research outputs found
Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance
PURPOSE: The prothrombotic state that occurs in uremic patients
may increase their cardiovascular risk. We studied hypertensive
patients with mild-to-moderate impairment of renal
function to determine if they had evidence of abnormalities in
the coagulation system.
SUBJECTS AND METHODS: Renal function was assessed in
382 patients with essential hypertension, in whom 24-hour creatinine
clearance, urinary protein excretion, and microalbuminuria
were measured. We evaluated the function of the coagulation
system by measurement of platelet counts, prothrombin
time, partial thromboplastin time, and plasma
antithrombin III, fibrinogen, D-dimer, and prothrombin fragment
1 1 2 levels.
RESULTS: Impaired renal function, defined as a creatinine
clearance of 30 to 89 mL per minute per 1.73m2 of body surface
area, was found in 168 (44%) of the patients. Age, blood pressure,
duration of hypertension, and plasma levels of fibrinogen,
D-dimer, prothrombin fragment 1 1 2, and lipoprotein(a)
were significantly greater in these patients than in those with
normal renal function; these differences persisted after adjustment
for potential confounders. Creatinine clearance was significantly
and inversely correlated with levels of plasma fibrinogen
(Spearman\u2019s rho 5 20.26, P ,0.001), D-dimer (rho 5
20.33, P ,0.001), and prothrombin fragment 1 1 2 (rho 5
20.20, P,0.001). Levels of plasma fibrinogen (P50.009) and
D-dimer (P 5 0.003) were correlated with renal function independent
of age, blood pressure, duration of hypertension, triglyceride
level, urinary protein excretion, and erythrocyte sedimentation
rate. Lipoprotein(a) levels were correlated with fibrinogen
(rho 5 0.16, P 5 0.003) and D-dimer (rho 5 0.26, P
,0.001) levels.
CONCLUSIONS: Increased plasma levels of fibrinogen,
D-dimer, and prothrombin fragment 1 1 2 are present in hypertensive
patients with mildly decreased creatinine clearance,
suggesting that the coagulation system is activated in these
patients
Abnormalities of glucose metabolism in patients with early renal failure
Abnormalities of glucose metabolism and hyperinsulinemia have been demonstrated in patients with end-stage renal disease and may contribute to the development of atherosclerotic complications in these patients. In the present study, we investigated the stage of renal failure in which abnormalities of glucose metabolism develop and whether these abnormalities were associated with an increased prevalence of cardiovascular events in patients with early renal failure. In 321 untreated essential hypertensive patients, we assessed renal function by measuring 24-h creatinine clearance, urinary protein excretion, and microalbuminuria; we assessed cardiovascular status by clinical and laboratory tests; and we measured plasma glucose, insulin, and C-peptide levels at fasting and after a 75-g oral glucose load. To evaluate insulin sensitivity, a hyperinsulinemic-euglycemic clamp was performed in a subgroup of 104 patients. Patients with creatinine clearance <30 ml . min(-1) . 1.73 m(-2), severe hypertension, BMI <30 kg/m(2), and diabetes or family history of diabetes were excluded. Hypertensive patients were found to be hyperinsulinemic when compared with 92 matched normotensive subjects. Early renal failure (creatinine clearance <90 ml . min 1.73 m(2)) caused by hypertensive nephrosclerosis was detected in 116 of 321 patients. Analysis of patients with varying degrees of renal function impairment demonstrated increased plasma glucose and insulin response to oral glucose load, decreased fasting glucose-to-insulin ratio, and reduced sensitivity to insulin only in those patients with creatinine clearance <50 ml . min(-1) . 1.73 m(2). Parameters of glucose metabolism were not correlated with creatinine clearance and microalbuminuria. Prevalence of atherosclerotic cardiovascular events was significantly related to reduction of creatinine clearance, but parameters of glucose metabolism were comparable in patients with and without evidence of atherosclerotic damage. Thus, in patients with hypertensive nephroselerosis and early impairment of glomerular filtration, alterations of glucose metabolism become evident only when creatinine clearance is <50 ml . min(-1) . 1.73 m(-2) and are not related to microalbuminuria and cardiovascular complications
Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension
Objective.-To investigate the association between lipoprotein(a) [Lp(a)] and other plasma lipids and apolipoproteins and target-organ damage (TOD) in patients with arteria[ hypertension. Design.-Cross-sectional study of a case series. Setting.-University medical center. Participants.-Lipoprotein(a) and apolipoproteins were analyzed in 277 untreated patients with mild to moderate essential hypertension and in 102 healthy controls. Apolipoprotein(a) [apo(a)] phenotypes were additionally analyzed in an independent sample set of 106 hypertensive and 105 control subjects. Main Outcome Measures.-Staging of TOD obtained according to World Health Organization guidelines by clinical evaluation, and laboratory tests including measurments of creatinine clearance, proteinuria, ophthalmoscopy, electrocardiography, echocardiography, and ultrasound examination of major arteries; levels of lipids, apolipoproteins, Lp(a), fibrinogen, and apo(a) phenotypes. Results.-Blood pressure, duration of hypertension, and levels of total cholesterol, low-density lipoprotein cholesterol, apolipoprotein B, Lp(a), and fibrinogen were significantly related to the presence and severity of TOD in univariate analysis. Stepwise multivariate analysis showed Lp(a) levels (P<.001) to be the best discriminator of the presence of TOD, followed by systolic blood pressure (P<.001), duration of hypertension (P=.01), and low-density lipoprotein cholesterol (P=.04). The Lp(a) levels were related to TOD independent of the level of blood pressure. We confirmed this association between Lp(a) concentrations and severity of TOD in a second independent sample set and observed a significantly higher frequency of low-molecular-weight apo(a) isoforms with increasing severity of TOD (P=.02). Conclusions.-Lipoprotein(a) and apo(a) phenotype are sensitive indicators of the severity of TOD in patients with essential hypertension, and their evaluation might permit identification of hypertensive subjects liable to the development of organ damage. The higher frequency of low-molecular-weight apo(a) isoforms in patients with TOD demonstrates a genetically determined risk for the development of TOD in hypertensive patients